Work

The Future of Chimeric Antigen Receptor T Cell Therapy

Year: 2023

Type: review

Source: Hematology/Oncology Clinics of North America

DOI: 10.1016/j.hoc.2023.06.005

Author: Eric L. Smith

Institution: Dana-Farber Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Understanding and addressing sub-optimal responses to CAR T cell therapy for Multiple Myeloma

OpenAlex ID: W4383874150

FWCI:

Cites: 32

Cited by:

Related to: 10